Over the past decade, several tumor-based predictors of cetuximab efficacy have been identified, yet most function as ...

The loop is beginning to close. Waste professionals who prepare now, by cleaning up data, understanding baseline costs, and ...

Insulet could be joining the competition to develop 'artificial pancreas' devices following the release of positive feasibility data for its solution. The Massachusetts-based company's 'hybrid ...